Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wensan tincture is a traditional Chinese medicine (TCM) transdermal formulation developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is designed for the treatment of upper respiratory tract infections (URTI), particularly those occurring in winter and spring, and is specifically used to alleviate URTI-related cough. The tincture is part of a "warming and dispersing" (Wensan) therapeutic strategy. In clinical studies, such as the Phase 0 SMART trial (ChiCTR2400080482), it is evaluated as a transdermal therapy compared against oral medications like montelukast sodium and other TCM powders. As a tincture, it is a liquid herbal extract typically applied to the skin to exert localized or systemic effects through acupoint stimulation or percutaneous absorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wensan tincture.